DSpace 集合:
https://scholars.lib.ntu.edu.tw/handle/123456789/64095
2024-03-29T11:31:48ZComparisons in analgesic effects between ultrasound-guided erector spinae plane block and surgical intercostal nerve block after video-assisted thoracoscopic surgery: A randomized controlled trial
https://scholars.lib.ntu.edu.tw/handle/123456789/641667
標題: Comparisons in analgesic effects between ultrasound-guided erector spinae plane block and surgical intercostal nerve block after video-assisted thoracoscopic surgery: A randomized controlled trial
作者: Sung, Chun-Sung; Wei, Tzu-Jung; Hung, Jung-Jyh; Su, Fu-Wei; Ho, Shih-I; Lin, Mong-Wei; Chan, Kuang-Cheng; CHUN-YU WU
摘要: This study aimed to compare the analgesic effects of anesthesiologist-administrated erector spinae plane block (ESPB) and surgeon-administrated intercostal nerve block (ICNB) following video-assisted thoracoscopic surgery (VATS).2024-03-14T00:00:00ZEffects of Transapical Transcatheter Mitral Valve Implantation
https://scholars.lib.ntu.edu.tw/handle/123456789/641666
標題: Effects of Transapical Transcatheter Mitral Valve Implantation
作者: Hsiung, Ming-Chon; Yin, Wei-Hsian; Lee, Yung-Tsai; Tsao, Tien-Ping; Lee, Kuo-Chen; KUAN-CHIH HUANG; Chen, Pei-En; Chiang, Wei-Hsuan; Tung, Tao-Hsin; Wei Jeng
摘要: Purpose: In this study, transapical transcatheter mitral valve-in-valve implantation (TAMVI) was compared with surgical redo mitral valve replacement (SRMVR) in terms of clinical outcomes. Methods: We retrospectively identified patients with degenerated mitral bioprosthesis or failed annuloplasty rings who underwent redo SRMVR or TAMVI at our medical center. Clinical outcomes were based on echocardiography results. Results: We retrospectively identified patients with symptomatic mitral bioprosthetic valve dysfunction (n = 58) and failed annuloplasty rings (n = 14) who underwent redo SRMVR (n = 36) or TAMVI (n = 36). The Society of Thoracic Surgeons Predicted Risk of Mortality scores were higher in the TAMVI group (median: 9.52) than in the SRMVR group (median: 5.59) (p-value = 0.02). TAMVI patients were more severe in New York Heart Association (p-value = 0.04). The total procedure time (skin to skin) and length of stay after procedures were significantly shorter in the TAMVI group, and no significant difference in mortality was noted after adjustment for confounding factors (p-value = 0.11). The overall mean mitral valve pressure gradient was lower in the TAMVI group than in the SRMVR group at 24 months (p < 0.01). Both groups presented a decrease in the severity of mitral and tricuspid regurgitation at 3-24 months. Conclusions: In conclusion, the statistical analysis is still not robust enough to make a claim that TAMVI is an appropriate alternative. The outcome of the patient appears only to be related to the patient's pre-operative STS score. Additional multi-center, longitudinal studies are warranted to adequately assess the effect of TAMVI.2021-01-01T00:00:00ZRenin-angiotensin system blockade in heart failure patients on long-term haemodialysis in Taiwan
https://scholars.lib.ntu.edu.tw/handle/123456789/641662
標題: Renin-angiotensin system blockade in heart failure patients on long-term haemodialysis in Taiwan
作者: Tang, Chao-Hsiun; Chen, Tso-Hsiao; Wang, Chia-Chen; Hong, Chuang-Ye; KUAN-CHIH HUANG; Sue, Yuh-Mou
摘要: Heart failure is among the most frequent complications of patients on long-term haemodialysis. The benefits of renin-angiotensin system (RAS) blockade on the outcomes of these patients have yet to be determined.2013-10-01T00:00:00ZCharacteristics and risk of interstitial lung disease in dermatomyositis and polymyositis: a retrospective cohort study in Japan
https://scholars.lib.ntu.edu.tw/handle/123456789/641655
標題: Characteristics and risk of interstitial lung disease in dermatomyositis and polymyositis: a retrospective cohort study in Japan
作者: Hu, Qingqing; KUAN-CHIH HUANG; Goh, Choo Hua; Tsuchiya, Yumi; Liu, Yanfang; Qiu, Hong
摘要: Dermatomyositis and polymyositis are rare, idiopathic inflammatory myopathies. Interstitial lung disease is one of the most common and potentially severe extra-muscular manifestations of dermatomyositis and polymyositis and is strongly linked to poor prognosis and early mortality. We aimed to characterise the demographic and clinical characteristics, incidence, and treatment of interstitial lung disease in patients with dermatomyositis or polymyositis. We conducted a retrospective cohort study using the Japan Medical Data Center healthcare claims database. Patients in the database with dermatomyositis (International Classification of Disease version 10 M33.0, M33.1, M33.9) or polymyositis (M33.2) from 01-Jan-2011 until 31-Dec-2019 were identified and followed-up for interstitial lung disease (J84.x) until death, dis-enrolment, or study end (31 December 2020). Cumulative risk curves compared interstitial lung disease risk in dermatomyositis versus polymyositis. Risk factors were evaluated by Cox proportional hazard models. There were 886 patients with dermatomyositis and 745 patients with polymyositis included in the cohort analysis. Mean (standard deviation) age at dermatomyositis/polymyositis diagnosis was 46.0 (16.0)/49.7 (13.3) years and 300 (34%)/104 (14%) developed interstitial lung disease during follow-up. The incidence rate of interstitial lung disease per 100 person-years was 18.42 (95% CI 16.42-20.59) for dermatomyositis and 5.39 (95% CI 4.43-6.50) for polymyositis. In the analysis adjusted for sex, age, and comorbidity score, the risk of interstitial lung disease was significantly higher in patients with dermatomyositis than with polymyositis (hazard ratio 2.72, 95% CI 2.18-3.41). The rate diverged markedly between the groups in the first year after diagnosis. Risk factors for interstitial lung disease were older age in dermatomyositis, female sex and rheumatoid arthritis in polymyositis. Glucocorticoids with/without tacrolimus were the most common newly prescribed drugs after the interstitial lung disease diagnosis. In conclusion, the risk of developing interstitial lung disease was significantly higher in patients with dermatomyositis than with polymyositis, and risk factors were different in the 2 patient groups.2023-10-11T00:00:00Z